(1) A reporting issuer that has a significant equity investee must disclose in its MD&A for each period referred to in subsection (2),
(a) summarized financial information of the equity investee, including the aggregated amounts of assets, liabilities, revenue and profit or loss; and
(b) the reporting issuer’s proportionate interest in the equity investee and any contingent issuance of securities by the equity investee that might significantly affect the reporting issuer’s share of profit or loss.
(2) The disclosure in subsection (1) must be provided for the following periods:
(a) in the case of annual MD&A, for the two most recently completed financial years; and
(b) in the case of interim MD&A for an issuer that is not providing disclosure in accordance with section 2.2.1 of Form 51-102F1, for the most recent year-todate interim period and the comparative year-to-date period presented in the interim financial report.
(3) Subsection (1) does not apply if
(a) the information required under that subsection has been disclosed in the financial statements to which the MD&A relates; or
(b) the issuer files separate financial statements of the equity investee for the periods referred to in subsection (2).